The abnormal transcriptions of KLFs were associated with cancer progression and as biomarkers could contribute to the diagnosis or differential diagnosis of benign and malignant lung diseases, such as increased KLF5 level in pulmonary hypertension, which was associated with smooth muscle proliferation and anti-apoptosis [97]. This evidence concerns the gene KLF5 and cancer.